Speakers: Dr. Richard O'Neal

Topic: Progress in Non-small Cell Lung Cancer

Learning Objectives: 

  • Recognize the transforming landscape of NSCLC management, new treatment options, longer survival.
  • Recognize the growing number of patients who are maintained chronically on immune checkpoint inhibitors and the impact that this can have on other comorbidities.
  • Identify adverse events related to novel targeted treatment agents.

 

Session date: 
03/05/2021 - 7:30am to 8:30am EST
Location: 
Medical Staff Auditorium/ MS Teams
701 Grove Road
Greenville, SC 29605
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    The University of South Carolina School of Medicine Greenville designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The University of South Carolina School of Medicine Greenville is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance

Please login or register to take this course.